Codes / ICD10CM / M1A.4711

M1A.4711 Other secondary chronic gout, right ankle and foot, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Secondary Chronic Gout, Right Ankle and Foot, With Tophus (Tophi)

Summary

Other secondary chronic gout, right ankle and foot, with tophus (tophi) is a form of arthritis affecting the right ankle and foot, resulting from elevated uric acid levels due to an identifiable underlying condition or cause. It leads to recurrent joint inflammation and potential tissue damage, with symptoms that may persist over time. Advanced stages involve the formation of tophi (urate crystal deposits) in the right ankle and foot area.

Causes

Other secondary chronic gout, right ankle and foot, with tophus (tophi) arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in the right ankle and foot joints and surrounding tissues, triggering inflammation and tophi formation.

Risk Factors

  • Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
  • Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
  • Chronic kidney disease or renal impairment
  • History of gout or hyperuricemia
  • Exposure to substances that disrupt uric acid excretion

Symptoms

  • Recurrent episodes of intense pain in the right ankle or foot
  • Persistent swelling, redness, and warmth in the affected area
  • Formation of tophi (hard, painless lumps) under the skin
  • Stiffness and limited joint mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may confirm urate crystals, while imaging (e.g., X-rays, ultrasound) can detect tophi or joint damage. Blood tests assess uric acid levels and rule out underlying conditions contributing to secondary gout.

Treatment Options

Treatment focuses on managing symptoms, reducing uric acid levels, and addressing the underlying cause. Medications may include anti-inflammatory drugs for acute flares, urate-lowering therapies (e.g., allopurinol), and agents to prevent tophi formation. Lifestyle modifications, such as dietary changes, are often recommended alongside medical management.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and adherence to treatment. With proper management, symptoms can be controlled, and tophi may shrink or stabilize. Regular follow-up is essential to monitor uric acid levels, adjust therapies, and prevent complications like joint damage or chronic pain.

Complications

Untreated or poorly managed gout can lead to chronic joint damage, persistent pain, and increased tophi formation. Severe cases may result in deformity, reduced mobility, or secondary infections. Underlying conditions contributing to secondary gout may also worsen without intervention.

Lifestyle & Prevention

  • Maintain a balanced diet low in purines (e.g., limit red meat, seafood, alcohol)
  • Stay hydrated to support uric acid excretion
  • Avoid medications that elevate uric acid levels when possible
  • Manage weight and exercise regularly to reduce joint stress
  • Follow prescribed treatments for underlying conditions

When to Seek Professional Help

Seek care if experiencing severe or persistent joint pain, swelling, or redness in the right ankle or foot. Prompt evaluation is needed for new tophi, recurrent flares, or signs of infection (e.g., fever, pus). Early intervention can prevent complications and improve outcomes.

Tips for Medical Coders

Document the presence of tophi and the specific location (right ankle and foot) to support the M1A.4711 code. Ensure the underlying cause of secondary gout is clearly identified and linked to the condition. Verify that clinical notes confirm chronicity and tophus formation to meet coding specificity requirements.

Book a walkthrough

M1A.4711 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.